Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in human leukemia cells

p38 MAPK/PP2Acα/TTP pathway on the connection of TNF-α and caspases activation on hydroquinone-induced apoptosis

(2013) Wen-Hsin Liu et al.   CARCINOGENESIS

Cross talk between p38MAPK and ERK is mediated through MAPK-mediated protein phosphatase 2A catalytic subunit α and MAPK phosphatase-1 expression in human leukemia U937 cells

(2013) Wen-Hsin Liu et al.   CELLULAR SIGNALLING

SP-1 regulation of MMP-9 expression requires Ser586in the PEST domain

(2012) Shubha Murthy et al.   BIOCHEMICAL JOURNAL

Amsacrine as a Topoisomerase II Poison: Importance of Drug–DNA Interactions

(2012) Adam C. Ketron et al.   BIOCHEMISTRY

CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability

(2012) Wen-Hsin Liu et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Assessment of amsacrine binding with DNA using UV–visible, circular dichroism and Raman spectroscopic techniques

(2012) Deepak Kumar Jangir et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features

(2011) Jenny Paupert et al.   CELL CYCLE

Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity

(2011) Ranjan Preet et al.   INTERNATIONAL JOURNAL OF CANCER

Discovery of 4-Anilinofuro[2,3-b]quinoline Derivatives as Selective and Orally Active Compounds against Non-Small-Cell Lung Cancers

(2011) Yu-Wen Chen et al.   JOURNAL OF MEDICINAL CHEMISTRY

Inhibition of NF-κB Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin

(2010) Tanvi S. Jani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway

(2010) Wen-Hsin Liu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways

(2009) C Guo et al.   ONCOGENE

The complexity of mitogen-activated protein kinases (MAPKs) made simple

(2008) M. Krishna et al.   CELLULAR AND MOLECULAR LIFE SCIENCES